These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6669799)

  • 1. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complex hospital treatment of pulmonary tuberculosis].
    Bondarev IM; Batmanov NIa; Shesterina MV; Gavrilenko VS; Tarasova EF
    Sov Med; 1980; (6):79-82. PubMed ID: 6998023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
    Shimko NP; Maĭovetskaia NS; Severina MV; Alimova LV
    Probl Tuberk; 1989; (3):60-4. PubMed ID: 2726714
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term results of a trial of short-term chemotherapy. French study 6.9.12].
    Roussel G; Bernadou M; Cheminat JC; Choffel C; Decroix G; Fréour P; Guillet P; Lemanissier AF; Milleron B; Molina C
    Rev Fr Mal Respir; 1983; 11(6):847-57. PubMed ID: 6366944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
    Osiĭnskiĭ IIu; Berezovskiĭ BA
    Probl Tuberk; 1989; (5):56-9. PubMed ID: 2748559
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
    Trkanjec Z; Tekavec J
    Tuber Lung Dis; 1993 Feb; 74(1):16-9. PubMed ID: 8495013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 15. [Profile of the patients lost to treatment in the National Anti-Tuberculosis Program in Madagascar].
    Rakotomanana F; Rabarijaona LP; Ratsitorahina M; Cauchoix B; Razafinimanana J; Ratsirahonana A; Boisier P; Aurégan G
    Sante; 1999; 9(4):225-9. PubMed ID: 10623869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
    Tsukamura M; Yoshii S; Yasuda Y; Saito H
    Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
    Long R; Scalcini M
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.